2024-LB: Reversal of Diabetes by Human Stem Cell–Derived Islets Implanted with an Immunomodulatory Microgel in a Retrievable Site

Introduction iTolerance. Stock/Shareholder; iTolerance, CorAmi. A. Japour: None. M. Revel: Employee; Kadimastem Ltd, Nes Ziona, Israel. C. Ricordi: Advisory Panel; Vertex Pharmaceuticals Incorporated. Consultant; iTolerance, Inc. G. Lanzoni: Stock/Shareholder; Novo Nordisk, Eli Lilly and Company, Pfizer Inc., Medtronic, UnitedHealth Group, Provention Bio, Inc. Funding iTolerance, Inc. (ITOL-SOW-00018263)